
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Neuropathology of genetic synucleinopathies with parkinsonism: Review of the literature
Susanne A. Schneider, Roy N. Alcalay
Movement Disorders (2017) Vol. 32, Iss. 11, pp. 1504-1523
Open Access | Times Cited: 274
Susanne A. Schneider, Roy N. Alcalay
Movement Disorders (2017) Vol. 32, Iss. 11, pp. 1504-1523
Open Access | Times Cited: 274
Showing 1-25 of 274 citing articles:
Selective neuronal vulnerability in Parkinson disease
D. James Surmeier, José Á. Obeso, Glenda M. Halliday
Nature reviews. Neuroscience (2017) Vol. 18, Iss. 2, pp. 101-113
Open Access | Times Cited: 896
D. James Surmeier, José Á. Obeso, Glenda M. Halliday
Nature reviews. Neuroscience (2017) Vol. 18, Iss. 2, pp. 101-113
Open Access | Times Cited: 896
Parkinson Disease Epidemiology, Pathology, Genetics, and Pathophysiology
David K. Simon, Caroline M. Tanner, Patrik Brundin
Clinics in Geriatric Medicine (2019) Vol. 36, Iss. 1, pp. 1-12
Open Access | Times Cited: 799
David K. Simon, Caroline M. Tanner, Patrik Brundin
Clinics in Geriatric Medicine (2019) Vol. 36, Iss. 1, pp. 1-12
Open Access | Times Cited: 799
Impact of microbiota on central nervous system and neurological diseases: the gut-brain axis
Qianquan Ma, Changsheng Xing, Wenyong Long, et al.
Journal of Neuroinflammation (2019) Vol. 16, Iss. 1
Open Access | Times Cited: 608
Qianquan Ma, Changsheng Xing, Wenyong Long, et al.
Journal of Neuroinflammation (2019) Vol. 16, Iss. 1
Open Access | Times Cited: 608
PINK1 and Parkin mitochondrial quality control: a source of regional vulnerability in Parkinson’s disease
Preston Ge, Valina L. Dawson, Ted M. Dawson
Molecular Neurodegeneration (2020) Vol. 15, Iss. 1
Open Access | Times Cited: 373
Preston Ge, Valina L. Dawson, Ted M. Dawson
Molecular Neurodegeneration (2020) Vol. 15, Iss. 1
Open Access | Times Cited: 373
Assessment of heterogeneity among participants in the Parkinson's Progression Markers Initiative cohort using α-synuclein seed amplification: a cross-sectional study
Andrew Siderowf, Luis Concha‐Marambio, David-Erick Lafontant, et al.
The Lancet Neurology (2023) Vol. 22, Iss. 5, pp. 407-417
Open Access | Times Cited: 362
Andrew Siderowf, Luis Concha‐Marambio, David-Erick Lafontant, et al.
The Lancet Neurology (2023) Vol. 22, Iss. 5, pp. 407-417
Open Access | Times Cited: 362
On Cell Loss and Selective Vulnerability of Neuronal Populations in Parkinson's Disease
Nicolas Giguère, Samuel Burke Nanni, Louis‐Éric Trudeau
Frontiers in Neurology (2018) Vol. 9
Open Access | Times Cited: 349
Nicolas Giguère, Samuel Burke Nanni, Louis‐Éric Trudeau
Frontiers in Neurology (2018) Vol. 9
Open Access | Times Cited: 349
Autophagy in Parkinson's Disease
Xu Hou, Jens O. Watzlawik, Fabienne C. Fiesel, et al.
Journal of Molecular Biology (2020) Vol. 432, Iss. 8, pp. 2651-2672
Open Access | Times Cited: 280
Xu Hou, Jens O. Watzlawik, Fabienne C. Fiesel, et al.
Journal of Molecular Biology (2020) Vol. 432, Iss. 8, pp. 2651-2672
Open Access | Times Cited: 280
Impaired dopamine metabolism in Parkinson’s disease pathogenesis
Anna Masato, Nicoletta Plotegher, Daniela Boassa, et al.
Molecular Neurodegeneration (2019) Vol. 14, Iss. 1
Open Access | Times Cited: 269
Anna Masato, Nicoletta Plotegher, Daniela Boassa, et al.
Molecular Neurodegeneration (2019) Vol. 14, Iss. 1
Open Access | Times Cited: 269
A biological definition of neuronal α-synuclein disease: towards an integrated staging system for research
Tanya Simuni, Lana M. Chahine, Kathleen L. Poston, et al.
The Lancet Neurology (2024) Vol. 23, Iss. 2, pp. 178-190
Closed Access | Times Cited: 236
Tanya Simuni, Lana M. Chahine, Kathleen L. Poston, et al.
The Lancet Neurology (2024) Vol. 23, Iss. 2, pp. 178-190
Closed Access | Times Cited: 236
Dementia with Lewy bodies and Parkinson’s disease-dementia: current concepts and controversies
K. A. Jellinger
Journal of Neural Transmission (2017) Vol. 125, Iss. 4, pp. 615-650
Closed Access | Times Cited: 231
K. A. Jellinger
Journal of Neural Transmission (2017) Vol. 125, Iss. 4, pp. 615-650
Closed Access | Times Cited: 231
A biological classification of Parkinson's disease: the SynNeurGe research diagnostic criteria
Günter U. Höglinger, Charles H. Adler, Daniela Berg, et al.
The Lancet Neurology (2024) Vol. 23, Iss. 2, pp. 191-204
Closed Access | Times Cited: 228
Günter U. Höglinger, Charles H. Adler, Daniela Berg, et al.
The Lancet Neurology (2024) Vol. 23, Iss. 2, pp. 191-204
Closed Access | Times Cited: 228
Genetics and Pathogenesis of Parkinson's Syndrome
Hui Ye, Laurie Robak, Meigen Yu, et al.
Annual Review of Pathology Mechanisms of Disease (2022) Vol. 18, Iss. 1, pp. 95-121
Open Access | Times Cited: 213
Hui Ye, Laurie Robak, Meigen Yu, et al.
Annual Review of Pathology Mechanisms of Disease (2022) Vol. 18, Iss. 1, pp. 95-121
Open Access | Times Cited: 213
The genetic landscape of Parkinson's disease
Ariane Lunati, Suzanne Lesage, Alexis Brice
Revue Neurologique (2018) Vol. 174, Iss. 9, pp. 628-643
Open Access | Times Cited: 189
Ariane Lunati, Suzanne Lesage, Alexis Brice
Revue Neurologique (2018) Vol. 174, Iss. 9, pp. 628-643
Open Access | Times Cited: 189
Cellular and Molecular Basis of Neurodegeneration in Parkinson Disease
Xiansi Zeng, Wen-Shuo Geng, Jing Jia, et al.
Frontiers in Aging Neuroscience (2018) Vol. 10
Open Access | Times Cited: 178
Xiansi Zeng, Wen-Shuo Geng, Jing Jia, et al.
Frontiers in Aging Neuroscience (2018) Vol. 10
Open Access | Times Cited: 178
Propagative α-synuclein seeds as serum biomarkers for synucleinopathies
Ayami Okuzumi, Taku Hatano, Gen Matsumoto, et al.
Nature Medicine (2023) Vol. 29, Iss. 6, pp. 1448-1455
Open Access | Times Cited: 160
Ayami Okuzumi, Taku Hatano, Gen Matsumoto, et al.
Nature Medicine (2023) Vol. 29, Iss. 6, pp. 1448-1455
Open Access | Times Cited: 160
Parkinson's disease in the Western Pacific Region
Shen‐Yang Lim, Ai Huey Tan, Azlina Ahmad‐Annuar, et al.
The Lancet Neurology (2019) Vol. 18, Iss. 9, pp. 865-879
Closed Access | Times Cited: 157
Shen‐Yang Lim, Ai Huey Tan, Azlina Ahmad‐Annuar, et al.
The Lancet Neurology (2019) Vol. 18, Iss. 9, pp. 865-879
Closed Access | Times Cited: 157
Motor and non-motor circuit disturbances in early Parkinson disease: which happens first?
Javier Blesa, Guglielmo Foffani, Benjamin Dehay, et al.
Nature reviews. Neuroscience (2021) Vol. 23, Iss. 2, pp. 115-128
Closed Access | Times Cited: 157
Javier Blesa, Guglielmo Foffani, Benjamin Dehay, et al.
Nature reviews. Neuroscience (2021) Vol. 23, Iss. 2, pp. 115-128
Closed Access | Times Cited: 157
The Genetics of Parkinson’s Disease and Implications for Clinical Practice
Jacob Day, Stephen Mullin
Genes (2021) Vol. 12, Iss. 7, pp. 1006-1006
Open Access | Times Cited: 154
Jacob Day, Stephen Mullin
Genes (2021) Vol. 12, Iss. 7, pp. 1006-1006
Open Access | Times Cited: 154
Mitochondrial damage-associated inflammation highlights biomarkers in PRKN/PINK1 parkinsonism
Max Borsche, Inke R. König, Sylvie Delcambre, et al.
Brain (2020) Vol. 143, Iss. 10, pp. 3041-3051
Open Access | Times Cited: 149
Max Borsche, Inke R. König, Sylvie Delcambre, et al.
Brain (2020) Vol. 143, Iss. 10, pp. 3041-3051
Open Access | Times Cited: 149
Gait parameters of Parkinson’s disease compared with healthy controls: a systematic review and meta-analysis
Ana Paula Janner Zanardi, Edson Soares da Silva, Rochelle Rocha Costa, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 149
Ana Paula Janner Zanardi, Edson Soares da Silva, Rochelle Rocha Costa, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 149
The role of genetics in Parkinson’s disease: a large cohort study in Chinese mainland population
Yuwen Zhao, Lixia Qin, Hongxu Pan, et al.
Brain (2020) Vol. 143, Iss. 7, pp. 2220-2234
Open Access | Times Cited: 139
Yuwen Zhao, Lixia Qin, Hongxu Pan, et al.
Brain (2020) Vol. 143, Iss. 7, pp. 2220-2234
Open Access | Times Cited: 139
Gut dysbiosis, defective autophagy and altered immune responses in neurodegenerative diseases: Tales of a vicious cycle
Saravana Babu Chidambaram, Musthafa Mohamed Essa, Annan Gopinath Rathipriya, et al.
Pharmacology & Therapeutics (2021) Vol. 231, pp. 107988-107988
Open Access | Times Cited: 121
Saravana Babu Chidambaram, Musthafa Mohamed Essa, Annan Gopinath Rathipriya, et al.
Pharmacology & Therapeutics (2021) Vol. 231, pp. 107988-107988
Open Access | Times Cited: 121
Alpha-synuclein research: defining strategic moves in the battle against Parkinson’s disease
Luís M. A. Oliveira, Thomas Gasser, Robert H. Edwards, et al.
npj Parkinson s Disease (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 114
Luís M. A. Oliveira, Thomas Gasser, Robert H. Edwards, et al.
npj Parkinson s Disease (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 114
The cell biology of Parkinson’s disease
Nikhil Panicker, Preston Ge, Valina L. Dawson, et al.
The Journal of Cell Biology (2021) Vol. 220, Iss. 4
Open Access | Times Cited: 110
Nikhil Panicker, Preston Ge, Valina L. Dawson, et al.
The Journal of Cell Biology (2021) Vol. 220, Iss. 4
Open Access | Times Cited: 110
Clinical and imaging evidence of brain-first and body-first Parkinson's disease
Jacob Horsager, Karoline Knudsen, Michael Sommerauer
Neurobiology of Disease (2022) Vol. 164, pp. 105626-105626
Open Access | Times Cited: 96
Jacob Horsager, Karoline Knudsen, Michael Sommerauer
Neurobiology of Disease (2022) Vol. 164, pp. 105626-105626
Open Access | Times Cited: 96